Skip to main content
. 2018 Jan 3;18(5):665–677. doi: 10.1038/s41397-017-0006-0

Fig. 3. Validation of PIK3CA pathway activation in asthmatic LCLs with differential responses to zileuton.

Fig. 3

. The barplots show normalized mean expression levels ± SEM for AKT (left plot), phospho-AKT (center plot) and PIK3CA (right plot) in ‘good’ and ‘poor’ responders (labels, x-axis), by treatment category (FBS = red; Sham (ethanol) = green; Zileuton = blue)